Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) dropped 4% during trading on Thursday . The company traded as low as $5.54 and last traded at $5.91. Approximately 400 shares were traded during trading, a decline of 70% from the average daily volume of 1,355 shares. The stock had previously closed at $6.16.
Nxera Pharma Price Performance
The business’s 50-day moving average price is $6.50 and its 200-day moving average price is $7.35.
About Nxera Pharma
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Featured Articles
- Five stocks we like better than Nxera Pharma
- Why Are These Companies Considered Blue Chips?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Are Treasury Bonds?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How is Compound Interest Calculated?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
